ECSP972004A - PROGRAMMED ABSORPTION OF A PHARMACEUTICAL SUBSTANCE 2,6- DIMETIL 4- (2 NITROFENIL) -1,4- DIHIDROPIRIDIN- 3,5- DIMETILO DICARBOXILATO (NIFEDIPINA) - Google Patents

PROGRAMMED ABSORPTION OF A PHARMACEUTICAL SUBSTANCE 2,6- DIMETIL 4- (2 NITROFENIL) -1,4- DIHIDROPIRIDIN- 3,5- DIMETILO DICARBOXILATO (NIFEDIPINA)

Info

Publication number
ECSP972004A
ECSP972004A ECSP972004A ECSP972004A EC SP972004 A ECSP972004 A EC SP972004A EC SP972004 A ECSP972004 A EC SP972004A EC SP972004 A ECSP972004 A EC SP972004A
Authority
EC
Ecuador
Prior art keywords
programmed
nifedipina
dimetilo
dihidropiridin
dicarboxilato
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Rabel Jaime David Kantor
Original Assignee
Rabel Jaime David Kantor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rabel Jaime David Kantor filed Critical Rabel Jaime David Kantor
Priority to ECSP972004 priority Critical patent/ECSP972004A/en
Publication of ECSP972004A publication Critical patent/ECSP972004A/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Una preparación farmacéutica de liberación programada de nifedipina en pequeños núcleos esféricos o glóbulos que logran IN-VIVO unos niveles en sangre regulados y terapéuticos y más concretamente se refiere a una formulación de Nifedipina para su administración una vez al día.A pharmaceutical preparation for the programmed release of nifedipine in small spherical nuclei or globules that achieve regulated and therapeutic blood levels IN-VIVO and more specifically refers to a formulation of Nifedipine for once-daily administration.

ECSP972004 1997-01-17 1997-01-17 PROGRAMMED ABSORPTION OF A PHARMACEUTICAL SUBSTANCE 2,6- DIMETIL 4- (2 NITROFENIL) -1,4- DIHIDROPIRIDIN- 3,5- DIMETILO DICARBOXILATO (NIFEDIPINA) ECSP972004A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP972004 ECSP972004A (en) 1997-01-17 1997-01-17 PROGRAMMED ABSORPTION OF A PHARMACEUTICAL SUBSTANCE 2,6- DIMETIL 4- (2 NITROFENIL) -1,4- DIHIDROPIRIDIN- 3,5- DIMETILO DICARBOXILATO (NIFEDIPINA)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP972004 ECSP972004A (en) 1997-01-17 1997-01-17 PROGRAMMED ABSORPTION OF A PHARMACEUTICAL SUBSTANCE 2,6- DIMETIL 4- (2 NITROFENIL) -1,4- DIHIDROPIRIDIN- 3,5- DIMETILO DICARBOXILATO (NIFEDIPINA)

Publications (1)

Publication Number Publication Date
ECSP972004A true ECSP972004A (en) 1998-02-13

Family

ID=42042838

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP972004 ECSP972004A (en) 1997-01-17 1997-01-17 PROGRAMMED ABSORPTION OF A PHARMACEUTICAL SUBSTANCE 2,6- DIMETIL 4- (2 NITROFENIL) -1,4- DIHIDROPIRIDIN- 3,5- DIMETILO DICARBOXILATO (NIFEDIPINA)

Country Status (1)

Country Link
EC (1) ECSP972004A (en)

Similar Documents

Publication Publication Date Title
DE60143889D1 (en) PARASITICIDE FORMULATION AND METHOD FOR PREPARING THIS FORMULATION
IL160641A0 (en) Carbohydrate binding domain containing fusion proteins for delivery of therapeutic and other agents, and compositions containing them
DE3778223D1 (en) BIODERODIBLE SYSTEM WITH CONTROLLED RELEASE OF THE MEDICINAL ACTIVE SUBSTANCE.
DE69510235D1 (en) TISSUE PAPER WITH DRUGS
PT88985A (en) Process for the preparation of nasal and ophthalmic pharmaceutical compositions containing azelastine
NO913649L (en) CONTROLLED DELIVERY DELIVERY FOR MACROMOLECULAR PROTEINS.
BRPI0408655A (en) formulations comprising an active agent and cocoa powder and their use
DE69629989D1 (en) PREPARATION FOR EXTERNAL USE FOR TREATING DERMATOS
TR200401603T4 (en) Vitamin D analogues
HN2000000050A (en) MUTUAL SALT OF AMLODIPINO AND ATORVASTATINA
AR005860A1 (en) AROMATIC HETERO-CYCLE COMPOUNDS, PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM, AND THEIR USE.
NO20031409D0 (en) Ion strength independent long-release pharmaceutical preparations
HUP0003840A2 (en) Controlled released medical formulation
RU95106680A (en) Bicyclic aromatic compounds and pharmaceutical and cosmetic compositions comprising them
DK122391D0 (en) THERAPEUTIC ACTIVITY, SUBSTITUTED BENZIMIDAZOLD DERIVATIVES AND PHYSIOLOGICALLY ACCEPTABLE SALTS THEREOF, AND PROCEDURE FOR PREPARING SAME
ES2186207T3 (en) METHOD FOR PREPARATION OF PHARMACEUTICAL FORMULATIONS.
AR036877A1 (en) PHARMACEUTICAL FORMULATION
DE69326627D1 (en) Therapeutic agent against impending abortion
BR9913982A (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivative and its use in the treatment of vascular diseases
NO995838L (en) New heteroethynylene compounds and pharmaceutical and cosmetic preparations containing the same
BR9713044A (en) Compound, use of a compound, process for its preparation, and pharmaceutical formulation.
PT1216035E (en) PREPARATION CONTAINING ACTIVE INGREDIENTS AND / OR AUXILIARY AGENTS WITH A CONTROLLED RELEASE OF THESE SUBSTANCES AND THE USE AND PRODUCTION THEREOF
BR0012775A (en) Low dose active ingredient microgranule tablet containing a directly compressible diluent, composition, and tablet preparation process
ATE210991T1 (en) COMPOSITION BASED ON PLANT EXTRACTS AND ESSENTIAL OILS USABLE IN THERAPEUTICS, COSMETICS AND DIETARY FOODS
ATE215367T1 (en) PHARMACEUTICAL PREPARATION FOR TOPICAL USE CONTAINING NIMESULIDE